CRISPR represents the next frontier in the cell and gene therapy landscape. Spearheaded by the first gene edited therapeutic awaiting FDA approval, a mounting wave of innovative technology developments and therapeutic applications are leading to a paradigm shift in our global healthcare systems.

To this end, the 4th Annual CRISPR 2.0 Congress is your definitive guide to showcasing the latest and greatest CRISPR tools being developed and applied in the therapeutic setting.

To know more visit: https://ter.li/rqwuyn